FENNEC PHARMACEUTICALS INC. Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Fennec Pharmaceuticals Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
  • Fennec Pharmaceuticals Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$5.55M, a 2% decline year-over-year.
  • Fennec Pharmaceuticals Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was $2.74M.
  • Fennec Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$16M, a 32.3% increase from 2022.
  • Fennec Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$23.7M, a 36.7% decline from 2021.
  • Fennec Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$17.3M, a 4.21% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$16M +$7.67M +32.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
2022 -$23.7M -$6.37M -36.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 -$17.3M +$763K +4.21% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-29
2020 -$18.1M -$5.33M -41.8% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-28
2019 -$12.8M -$2.89M -29.2% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-30
2018 -$9.89M -$2.84M -40.3% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-14
2017 -$7.05M -$4.26M -153% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-15
2016 -$2.79M -$2.13M -323% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-28
2015 -$659K +$1.52M +69.7% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-29
2014 -$2.18M -$4.02M -218% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-28
2013 $1.85M +$7.01M Jan 1, 2013 Dec 31, 2013 10-Q 2015-11-12
2012 -$5.16M -$9.85M -210% Jan 1, 2012 Dec 31, 2012 10-Q 2014-11-13
2011 $4.69M +$12.5M Jan 1, 2011 Dec 31, 2011 10-Q 2014-11-13
2010 -$7.82M Jan 1, 2010 Dec 31, 2010 10-Q 2014-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.